Novartis (NVS)

• Market cap: $195B
• 1 day: -0.34%
• 5 days: -1.05%
• 1 month: -1.58%
• 3 months: -16.29%
• 6 months: -12.76%
• Year to date: 0.40%
• 1 year: -9.91%
• 5 years: 1.67%
• 10 years: -3.89%

About: Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Employees: 76,057

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 100 | Existing positions closed: 83

0% less funds holding

Funds holding: 1,294 [Q2] → 1,289 (-5) [Q3]

0.59% less ownership

Funds ownership: 6.64% [Q2] → 6.04% (-0.59%) [Q3]

2% less capital invested

Capital invested by funds: $15.5B [Q2] → $15.2B (-$257M) [Q3]

13% less funds holding in top 10

Funds holding in top 10: 15 [Q2] → 13 (-2) [Q3]

15% less repeat investments, than reductions

Existing positions increased: 405 | Existing positions reduced: 474

42% less call options, than puts

Call options by funds: $171M | Put options by funds: $294M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $120 23% upside
• Avg. target: $120 23% upside
• High target: $120 23% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

BMO Capital Etzer Darout 22% 1-year accuracy 9 / 41 met price target

23% upside $120

Market Perform Maintained

30 Oct 2024